Biopharmaceuticals
Cardiology
Licensing
News Release - December 12, 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Source: Cardiome Pharma
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.